Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Cognition Therapeutics (NASDAQ:CGTX) with a Buy rating and announces Price Target of $10.
Cognition Therapeutics (NASDAQ:CGTX) will host a conference call at 08:00 AM ET on March 30, 2022, to discuss Q4 2021 earnings results.
How to Attend Cognition Therapeutics (CGTX) Conference Call
Follow this link to access the live webcast.
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.